Elsevier

Atherosclerosis

Volume 75, Issue 1, January 1989, Pages 1-6
Atherosclerosis

Research paper
Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis

https://doi.org/10.1016/0021-9150(89)90200-1Get rights and content

Abstract

Elevated plasma homocysteine and lipid levels are risk factors for atherosclerosis. The plasma levels of homocysteine, determined in acid hydrolyzates of plasma, were found to be correlated with total cholesterol (r = 0.47, P < 0.001), triglycerides (r = 0.40, P < 0.01), and body mass index (r = 0.42, P < 0.01) in 52 males, aged 30–60. A group of 12 male survivors of acute myocardial infarction was given pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin for 21 days. The plasma concentrations of homocysteine and α-amino adipic acid declined to 68% (P < 0.001) and 57% (P < 0.001) of the pretreatment values, and the cholesterol, triglycerides, and LDL apo B declined to 79% (P < 0.001), 68% (P < 0.01), and 63% (P < 0.001) of the pretreatment values, respectively. The results suggest a new strategy for control of the metabolic abnormalities in atherosclerosis through the use of naturally occurring, non-toxic nutrients which minimize homocysteine accumulation.

References (25)

  • S.S. Kang et al.

    Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

    J. Clin. Invest.

    (1986)
  • R. Gaggi et al.

    The role of homocysteine in the pathogenesis of arteriosclerosis

  • Cited by (70)

    • Phosphorylation of GSK-3β and reduction of apoptosis as targets of troxerutin effect on reperfusion injury of diabetic myocardium

      2015, European Journal of Pharmacology
      Citation Excerpt :

      Troxerutin or vitamin P4, is a flavonoid that can be found in tea, coffee, cereal and a variety of fruits and vegetables. This flavonoid has attracted much attention due to its pharmacological properties such as significant anti-inflammatory, antioxidant, and anti-thrombolytic activities (Blasig et al., 1988; Heidarzadeh et al., 2014; Olszewski et al., 1989). Previous experiments have also confirmed the tissue protective effect of troxerutin in kidney (Shao-hua et al., 2009), liver (Zhang et al., 2009) and brain (Lu et al., 2010, 2011) injuries.

    • Hyperhomocysteinemia induced by feeding rats diets rich in dl-homocysteine thiolactone promotes alterations on carotid reactivity independent of arterial structure

      2009, Vascular Pharmacology
      Citation Excerpt :

      This is an important observation since it allowed us to compare the effects of the time–course treatment with homocysteine on the vascular functionality and morphology, further discarding the influence of the plasma level of homocysteine in this response. A positive correlation between plasma levels of homocysteine and cholesterol has been found in patients with HHcy as well as in experimental animals (Olszewski et al., 1989; McCully et al., 1990). The accumulation of lipids in the arterial wall, particularly cholesterol, is a major event preceding the formation of atherosclerotic lesions (Raines and Ross, 1993; Nordestgaard, 1996).

    • Medical management of peripheral arterial disease

      2005, Journal of Thrombosis and Haemostasis
    View all citing articles on Scopus

    Supported by National Grant KPBR MZ 09 from the Polish Ministry of Health.

    View full text